PepDiana
Back to Evidence
Primary experimental recordPositive observation

PMC5446464::ACT049595

LVQGS

Evidence text

Paper-level observation

Table 1: Soy bean, LVQGS, IC50 43.7 µM.
tableConfidence: medium

Assay observation

Activity
Metabolic/Cardiovascular
Subtype
ACE Inhibitor
Measure
other
Comparator
=
Raw observation
43.7 µM
Normalized measurement
=43.7 µM
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
Angiotensin-I-converting enzyme
Assay method
Not reported by source
Sequence
LVQGS
Standardization
ready simple

Source publication

STRUCTURAL CHARACTERISTICS AND ANTIHYPERTENSIVE EFFECTS OF ANGIOTENSIN-I-CONVERTING ENZYME INHIBITORY PEPTIDES IN THE RENIN-ANGIOTENSIN AND KALLIKREIN KININ SYSTEMS.

African Journal of Traditional, Complementary, and Alternative Medicines · 2017

DOI 10.21010/ajtcam.v14i2.39 PMC5446464
Parent mention Integrated peptide

Related peptide identities

PEPDIA-PLP-003870PEPDIA-INT-031918

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.